J Korean Acad Rehabil Med Search


Journal of the Korean Academy of Rehabilitation Medicine 1996;20(3):1.
Drug Therapy in Rheumatoid Arthritis
Bin Yoo, M.D.
Department of Clinical Immunology, Asan Medical Center, University of Ulsan, College of Medicine
류마티스 관절염의 약물치료
울산의대 서울 중앙병원 면역내과

Rheumatoid arthritis(RA) is a chronic systemic autoimmune disease with high mortality. Treatment of RA has always been challenging since the early recognition of this disease back in mid 18th century. The etiology of RA is still unknown and specific therapy for the cure is yet to come. Multidisciplinary approach is required for the management and drug therapy is one of the many management modalities for this chronic disease.

Drugs ranging from simple analgesics to antiinflammatory drugs to powerful immunomodulators have been used for the treatment of RA with varying success. In the last decade, the major change in the therapeutic approach to the treatment of patients with RA has been the widespread use of methotrexate alone or in combination with other conventional disease modifying autirheumatic drugs(DMARDs). Despite the availability of agents that are believed to be disease modifying, many patients either do not respond adequately to available agents or must discontinue their use because of intolerable or dangerous adverse reactions.

For this reason, researchers continue to search for more efficacious and less toxic agents for patients with RA.

Key Words: Rheumatoid arthritis, Drug, Combination therapy, Methotrexate


Browse all articles >

Terms of Use   |   Privacy Polity
Editorial Office
Department of Rehabilitation Medicine, Seoul National University Hospital
101 Daehak-ro, Jongno-gu, Seoul, Korea
Tel: +82-10-8678-2671    Fax: +82-2-6072-5244    E-mail: edit@e-arm.org; edit.karm@gmail.com
Business Registration: 110-82-07460                

Copyright © 2024 by Korean Academy of Rehabilitation Medicine.

Developed in M2PI

Close layer